Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01944579 · ClinicalTrials.gov registry record · NA
Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria
A NA study, sponsored by Janet Novotny.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT01944579: Completed NA study, sponsored by Janet Novotny.
NCT01944579 is a NA study that has completed, run by Janet Novotny. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01944579, a NA study, has completed, sponsored by Janet Novotny.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Intestinal bacteria can metabolize unabsorbed polyphenols (plant compounds) to produce smaller molecules which may impact health. In addition, evidence suggests that this process may be affected by body fatness. This study aims to investigate absorption of blackberry polyphenols, their impact on intestinal bacteria, polyphenol metabolites formed by intestinal bacteria, and how these processes differ for obese and lean individuals. It is hypothesized that polyphenol absorption and metabolism will differ between obese and lean individuals and that differences in intestinal microbiota may play a role.
Primary Outcome
Feces will be analyzed for bacterial typing at 0 and 4 weeks of each diet period.
Interventions
- OTHER Control
- OTHER Blackberries
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01944579 record still lists
NCT01944579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT01944579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01944579 about?
NCT01944579 is a clinical study titled "Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria". Intestinal bacteria can metabolize unabsorbed polyphenols (plant compounds) to produce smaller molecules which may impact health. In addition, evidence suggests that this process may be affected by body fatness. This study aims to investigate absorption of blackberry polyphenols, their impact on int...
What is the current status of trial NCT01944579?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2013-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01944579?
The interventions under investigation include: Control (OTHER), Blackberries (OTHER).
Who is sponsoring clinical trial NCT01944579?
This trial is sponsored by Janet Novotny, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01944579's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia